💊 Fluticasone (Fluticasone Propionate And Salmeterol)
An orally inhaled powder combining a corticosteroid and a long-acting beta2-agonist. It is taken twice daily for asthma and for maintenance treatment of airflow obstruction in COPD. It is not for relief of sudden, acute breathing difficulty, and the dose is set by your doctor or pharmacist.
In Arabic: فلوتيكازون بروبيونات وسالميتيرول (استنشاق)✅ What it is used for
- Twice-daily treatment of asthma in patients aged 4 years and older
- Maintenance treatment of airflow obstruction and reduction of exacerbations in COPD (including chronic bronchitis and/or emphysema)
- For asthma patients not adequately controlled on a long-term control medicine such as an inhaled corticosteroid, or whose disease warrants starting both an ICS and a LABA
- NOT indicated for relief of acute bronchospasm
🧪 Active ingredient
Fluticasone propionate: a synthetic anti-inflammatory corticosteroid. Salmeterol: a selective long-acting beta2-agonist that relaxes (widens) the airways.
🌿 Benefits
- Reduces airway inflammation and widens the airways with a single inhaler
- Improvement in asthma control can occur within 30 minutes of starting, although maximum benefit may take 1 week or longer
- Reduces COPD exacerbations in patients with a history of exacerbations
📝 How to use
- For oral inhalation only: 1 inhalation twice daily, approximately 12 hours apart
- The dose and strength are set by your doctor or pharmacist based on severity; do not change them yourself
- Rinse your mouth with water after each inhalation without swallowing, to help reduce the risk of oral thrush (candidiasis)
- Do not take more than 1 inhalation twice daily
- Do not use another medicine containing a LABA for any reason
- If asthma symptoms occur between doses, use an inhaled short-acting beta2-agonist for immediate relief
💊 Dosage forms
- Inhalation powder in an inhaler containing a foil blister strip
- Strengths: fluticasone propionate 100, 250, or 500 mcg with salmeterol 50 mcg per blister
⚠️ Common side effects
- Upper respiratory tract infection and pharyngitis
- Hoarseness (dysphonia)
- Oral candidiasis (thrush)
- Bronchitis and cough
- Headache
- Nausea and vomiting
- Pneumonia (in COPD patients)
- Throat irritation and musculoskeletal pain
🚨 Serious — seek medical help
- Serious asthma-related events (hospitalization, intubation, death) with LABA use
- Paradoxical bronchospasm (worsened breathing after a dose) – stop the medicine and seek alternative therapy
- Cardiovascular and central nervous system effects
- Pneumonia in COPD patients
- Adrenal suppression and hypercorticism
- Reduced bone mineral density and growth effects in children
- Glaucoma and cataracts with long-term use
- Hypersensitivity reactions
⛔ Do not use if
- Primary treatment of status asthmaticus or other acute episodes of asthma or COPD requiring intensive measures
- Severe hypersensitivity to milk proteins
- Demonstrated hypersensitivity to fluticasone propionate, salmeterol, or any of the excipients
❗ Warnings & precautions
- Not for treating acute symptoms; do not start in acutely deteriorating asthma or COPD
- LABA monotherapy increases the risk of serious asthma-related events
- Increased risk of pneumonia in COPD; monitor for signs and symptoms
- May worsen existing infections (e.g., tuberculosis; fungal, bacterial, viral or parasitic infections; ocular herpes simplex); chickenpox or measles may be more serious in susceptible patients
- When transferring from systemic corticosteroids, taper slowly to avoid impaired adrenal function
- Use with caution in cardiovascular or central nervous system disorders due to beta-adrenergic stimulation
- Assess bone mineral density periodically and monitor growth in children
- Consider ophthalmology referral for ocular symptoms or long-term use
- Be alert to eosinophilic conditions, hypokalemia, and hyperglycemia
- Contains lactose (with milk proteins)
- Do not use without consulting your doctor or pharmacist
🔄 Drug interactions
- Strong CYP3A4 inhibitors (e.g., ritonavir, ketoconazole, clarithromycin, itraconazole): use not recommended; may increase systemic corticosteroid and cardiovascular effects
- MAO inhibitors and tricyclic antidepressants: use with extreme caution; may potentiate salmeterol's effect on the vascular system
- Beta-blockers: use with caution; may block bronchodilation and cause severe bronchospasm
- Non-potassium-sparing diuretics: use with caution; ECG changes and/or hypokalemia may worsen
- Do not use with other LABA-containing medicines
- Has been used with short-acting beta2-agonists, methylxanthines, and intranasal corticosteroids without adverse drug reactions
- Tell your doctor or pharmacist about all medicines you take
🤰 Pregnancy
There are insufficient data on use in pregnant women. Animal studies showed adverse effects at maternally toxic doses. Poorly controlled asthma increases risks in pregnancy and for the baby, so consult your doctor before using during pregnancy.
🍼 Breastfeeding
The provided label text does not include sufficient information on breastfeeding; consult your doctor before use while breastfeeding.
🧒 Children
Indicated for asthma in patients aged 4 years and older; for ages 4 to 11 only the 100 mcg/50 mcg strength is used, as directed by the doctor. Safety and effectiveness under 4 years are not established. Inhaled corticosteroids may reduce growth velocity, so growth should be monitored.
👴 Older adults
No dosage adjustment is warranted. COPD patients aged 65 and older had a higher incidence of serious adverse events and a greater excess risk of pneumonia. Special caution is needed in those with cardiovascular disease.
🌡️ Storage
Store at 20° to 25°C (68° to 77°F) in a dry place away from direct heat or sunlight and out of reach of children. Keep inside the unopened foil pouch and remove only immediately before first use. Discard 1 month after opening the pouch or when the counter reads 0, whichever comes first. The inhaler is not reusable; do not take it apart.
⏰ Missed dose
The label text provided gives no specific missed-dose instructions. Do not double the dose or exceed 1 inhalation twice daily, and ask your doctor or pharmacist.
🆘 Overdose
No human overdose data have been reported. Signs may include excessive beta-adrenergic stimulation such as palpitations, fast heart rate, tremor, headache, seizures, and blood pressure changes or arrhythmias. Seek emergency care if overdose is suspected; treatment is discontinuation with symptomatic/supportive therapy and cardiac monitoring.
💰 Price & brands in your area
🏛️ Official price in Palestine — Ministry of Health price list:
| Product | Company | Pack | Price |
|---|---|---|---|
| FRINASE NASAL SPRAY FLUTICASONE PROPIONATE50MCG | Jepharm Co. | 1 NASAL SPRAY | 34 ₪ |
| ZALINASE PLUS NASAL SPRAY Azelastine HCL & Fluticasone Propionate | Pharmacare Company | 15 gm | 45 ₪ |
📍 Find the nearest pharmacy
Your location is used only in your browser to show nearby pharmacies — we don't store it.
Open in Google Maps👨⚕️ For healthcare professionals
Mechanism of action
Combines fluticasone propionate (trifluorinated corticosteroid with anti-inflammatory activity and high affinity for the glucocorticoid receptor) and salmeterol xinafoate (selective LABA, at least 50 times more selective for beta2-adrenoceptors than albuterol). The two classes act through different mechanisms on clinical, physiologic, and inflammatory indices.
Labeled dosing
Asthma, age 12 years and older: 1 inhalation twice daily about 12 hours apart, 100/50, 250/50, or 500/50 mcg based on severity (maximum 500/50 mcg twice daily). Children 4 to 11 years: 100/50 mcg twice daily. COPD: 250/50 mcg twice daily (the only approved dose). Oral inhalation only. The dose is set by the doctor or pharmacist.
- Not for relief of acute bronchospasm; a short-acting beta2-agonist is needed for rescue
- Advise mouth rinsing to reduce oropharyngeal candidiasis risk
- If a previously effective regimen fails, reevaluate and consider a higher strength or additional therapy
- Avoid concomitant strong CYP3A4 inhibitors
- Monitor bone density, pediatric growth, eyes, adrenal function, and pneumonia
🎓 Key points for students
- Combines an inhaled corticosteroid with a LABA in one inhaler
- The only approved COPD dose is 250/50 mcg twice daily
- Not for acute bronchospasm relief
- Milk protein in the lactose excipient is a contraindication in severe milk-protein hypersensitivity
- Key risks: oral candidiasis, pneumonia in COPD, adrenal suppression
- Strong CYP3A4 inhibitors (e.g., ritonavir) increase systemic fluticasone exposure
EME runs your whole clinic: appointments with WhatsApp reminders, patient files, finance & inventory, a patient portal and a members-price medical store — with your data isolated and protected.
Try EME free How we protect your data❓ FAQ
Can this medicine be used for sudden shortness of breath?
No. It is not indicated for relief of acute bronchospasm. Use the short-acting reliever inhaler your doctor prescribed for immediate relief.
Why should I rinse my mouth after inhaling?
To help reduce the risk of oral thrush (candidiasis) in the mouth and throat. Rinse with water and do not swallow it.
Can I take extra inhalations to improve symptoms?
No. The dose is 1 inhalation twice daily. More inhalations are not recommended because of a higher chance of side effects. Talk to your doctor if symptoms do not improve.
How soon does it start working?
Improvement in asthma control can occur within 30 minutes of starting, but maximum benefit may take 1 week or longer, and varies between individuals.
Is it suitable for children?
It is used for asthma from age 4 years, using the 100/50 mcg strength for ages 4 to 11, under a doctor's guidance with monitoring of growth.
⚕️ For education only — not a substitute for advice from your doctor or pharmacist. Do not start or stop any medicine without advice. Source: official FDA drug label via openFDA (2025-05), simplified. Updated: 2026-11-16.